Your browser doesn't support javascript.
loading
Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic leukemia (CLL2-BCG): Final analysis of a multicenter, open-label phase-II-trial.
Cramer, Paula; von Tresckow, Julia; Fink, Anna-Maria; Robrecht, Sandra; Giza, Adam; Tausch, Eugen; Müller, Lothar; Knauf, Wolfgang; Zingerle, Matthias; Al-Sawaf, Othman; Langerbeins, Petra; Fischer, Kirsten; Kreuzer, Karl-Anton; Kneba, Michael; Wendtner, Clemens-Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael.
Afiliação
  • Cramer P; Department I of Internal Medicine and German CLL Study Group; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
  • von Tresckow J; Department I of Internal Medicine and German CLL Study Group; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
  • Fink AM; Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Robrecht S; Department I of Internal Medicine and German CLL Study Group; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
  • Giza A; Department I of Internal Medicine and German CLL Study Group; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
  • Tausch E; Department I of Internal Medicine and German CLL Study Group; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
  • Müller L; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
  • Knauf W; Practice for Hematology and Oncology UnterEms, Leer, Germany.
  • Zingerle M; Practice for Hematology and Oncology Bethanien, Frankfurt/Main, Germany.
  • Al-Sawaf O; Practice for Hematology and Oncology Pasing and Fürstenfeldbruck, Munich, Germany.
  • Langerbeins P; Department I of Internal Medicine and German CLL Study Group; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
  • Fischer K; Department I of Internal Medicine and German CLL Study Group; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
  • Kreuzer KA; Department I of Internal Medicine and German CLL Study Group; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
  • Kneba M; Department I of Internal Medicine and German CLL Study Group; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
  • Wendtner CM; Department of Internal Medicine II, Campus Kiel, University of Schleswig-Holstein, Kiel, Germany.
  • Stilgenbauer S; Department of Hematology, Oncology, Immunology, Palliative Care, Infectious Diseases and Tropical Medicine, Munich Clinic Schwabing, Munich, Germany.
  • Eichhorst B; Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany.
  • Hallek M; Department I of Internal Medicine and German CLL Study Group; Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University of Cologne, Faculty of Medicine and University Hospital of Cologne, Cologne, Germany.
Am J Hematol ; 99(6): 1192-1195, 2024 06.
Article em En | MEDLINE | ID: mdl-38578022
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Purinas / Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Quinazolinonas / Anticorpos Monoclonais Humanizados / Cloridrato de Bendamustina Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Purinas / Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica / Quinazolinonas / Anticorpos Monoclonais Humanizados / Cloridrato de Bendamustina Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha